Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The MicroArray Quality Control Consortium, which brings together over 100 scientists from academia, industry and the government, presents the results of a detailed analysis of the performance of seven DNA microarray platforms. Cover art: Erin Boyle
As CEO of one of the first companies to make protein delivery into a profitable business, Abe Abuchowski knows what it takes to bring a new technology to market. Although his technology—PEGylation—is now considered an industry gold standard, its three-decade development history illustrates the often rocky path to commercial success for platforms.
As the first 'systems biology' companies achieve some measure of success, the question remains whether systems biology can provide a viable business model. Karl Thiel investigates.
By rejecting gene-spliced ingredients in their products, some major food companies may be making foods that are less safe and wholesome for consumers—and that expose them to litigation.
Despite the boom in genetic tests available in US laboratories, oversight remains patchy. A survey of laboratory directors suggests that mandatory proficiency testing would result in fewer errors.
The US Environmental Protection Agency is developing a new guidance that outlines best practice in the submission, quality assurance, analysis and management of genomics data for environmental applications.
Objective quality control indices are needed to facilitate clinical implementation of DNA microarrays used in transcriptional profiling as well as other types of genomic analysis.
The first formal results of a consortium of over 150 regulatory, industrial and academic scientists that set out to conduct a cross-platform analysis of DNA microarray expression data obtained from two, commercially available RNA samples.